NBIX
Neurocrine Biosciences Inc#89 · 2022BreakoutBYearly return
+35%
Peak return
+46%
Max drawdown
-25%
ADR (20 days)
+2.7%
Base
29 days / -8.5%
Prior run
+33%
Breakout volume
3.6x
Pivot
$99.41
Catalyst Earnings/Guidance2022-08-04Neurocrine Biosciences (NBIX) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Materials · Materials/Commodities
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare NBIX with the current market directly.